Yeasts as Potential Source for Prebiotic β-Glucan: Role in Human Nutrition and Health by Oliva-Neto, Pedro De et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 16
Yeasts as Potential Source for Prebiotic β-Glucan: Role in
Human Nutrition and Health
Pedro De Oliva-Neto, Sidmeire Santos Oliveira,
Estevão Zilioli and Márcia Zilioli Bellini
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/63647
Abstract
Yeasts are a potential source for prebiotic β-glucans. This polysaccharide is character‐
ized  by  D-glucose  monomers  linked  by  β-glycosidic  bonds.  There  are  significant
structural differences in β-glucans depending on the source and method in which they
are obtaining. This polymer is a healthier food and feed additive. Numerous benefi‐
cial  effects have been attributed to this polymer,  in particular immunomodulatory
action. Different studies confirm safe use and applicability of β-glucans in medicine for
the treatment of diseases (cancer, infections, respiratory diseases) and reduction in
glucose and cholesterol levels. Many advances in the processes to obtain β-glucans have
been presented, including extraction, purification, and chemical modification, aiming
the biological properties and yield. One limitation of their use is the cost, so a strate‐
gic discussion of the use of yeast biomass was performed for the production of β-
glucans. An extensive and systematic review was undertaken to contribute to the science
and technology to obtain β-glucans and their use in different applications.
Keywords: β-glucans, chemical properties, extraction, purification, immunostimulat‐
ing properties
1. Introduction
One of the important biopolymers present in some cereals and fungi is the β-glucan. This
polysaccharide plays an important role in the immune system, skin protection, among others.
In addition to their cholesterol-lowering and potential cancer-preventing properties, β-glucans
may be useful in controlling blood glucose levels. The β-D-glucans from yeast and some plants
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have been shown to have antitumor and antibacterial activity when injected or ingested by
animals in experimentation [1–7].
Cereal grains, such as barley, oats, and rye, and fungi, such as Aspergillus, Saccharomyces, and
mushrooms, contain β-D-glucans [8, 9]. The concentration of β-glucan in oats ranges from 1.9
to 8.0% [10, 11]. In barley grains, these values can reach 3.5–4.8% [12]. These variations are
associated with genotype of grain and location and the environmental conditions in which the
culture was grown and may result in variation in the quality of β-glucan. This problem is
reduced if the source is from microorganisms, which are cultured in defined conditions, and
they are not dependent from the location or the environmental conditions.
2. Chemical structure of β-glucans
Glucans are glucose polymers, classified according to their interchain linkage as being either
α- or β-linked. β-glucans are a heterogeneous group of non-starch polysaccharides, consist‐
ing of D-glucose monomers linked by β-glycosidic bonds [13]. The central skeleton of the β-
glucans is formed by linear monomers of D-glucose connected at position β-(1-3), with side
chains attached to β-(1-6) or β-(1-4)-D-glucopyranosyl unit linkage (Figure 1). In yeast, the
skeleton is branching at β-(1-6) and in plants and bacteria at β-(1-4) unit linkage [14–16]. In
mushrooms, molecules with binding β-(1-6) and others with connections β-(1-6) and β-(1-4),
whether or not linked to protein, were reported [17]. Significant structural differences in β-
glucans are characterized by the glycosidic linkage ratios depending on both the source and
method of isolation. In the cereal β-glucans, for example, the trisaccharide-to-tetrasaccharide
ratios follow the order of wheat (4.2–4.5), barley (2.8–3.3), and oat (2.0–2.4) [18].
Figure 1. Polymer of β (1-3)-D-glycopyranosyl units with branching at β (1-6) and β (1-4)-D-glycopyranosyl units.
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3. Biological properties and applications of β-glucans
In the last decades, the β-glucans have received special attention for its biological activity.
Numerous beneficial effects have been attributed to this polymer, in particular due to its
immunomodulatory potential. However, beyond the modulatory action of the immune
system, several other activities related to β-glucans have been evaluated and proven, as their
antitumoral, anti-inflammatory, antimutagenic, and antioxidant action, their hypoglycemic
and hypocholesterolemic capacity, and also their protective effect against infections [19].
The β-glucans have a long scientific history, encompassing hundreds of studies. However, this
molecule is not properly explored even in therapy, as an additive in food or feed, probably
due to its relatively expensive price—about U$ 36/kg (brand Macrogard; Biorigin, Quatá, São
Paulo, Brazil). Research involving the biological activity of this polymer originated in the
1940s, with the renowned scientist Pillemer and his colleagues, who obtained a crude-insoluble
extract of the cell wall of the Saccharomyces cerevisiae, called zymosan, consisting of proteins,
chitin, β-glucan, mannans, and lipids. According to the authors, this extract was able to
stimulate the immune response in a non-specific manner [20]. Clinical studies in humans
involving the β-glucans began in the 1970s, even before the evidence of their mode of action
on the immune system, with reports of curing different types of cancer, including breast cancer,
melanoma, and adenosquamous carcinoma of the lung after the application of extracts of β-
glucans [21].
3.1. Immune system and immunomodulatory activity of β-glucans
The immune system operates seeking to protect the organism from infections that can be
caused by various agents, including bacteria, viruses, fungi, and parasites. The cells and
molecules of the immune system are highly specialized in the defense against infection.
Individuals with a compromised immune defense system due to various factors, such as age,
chronic infection, or malnutrition, are subject to several problems, including arthritis, reduced
healing capacity, reduced proliferation of bone marrow cells with consequent low defense cell
counts, anemia, and increased incidence of all types of microbial infections. Studies also show
that one of the main elements of the process of aging is a decrease in the functional effective‐
ness of the immune system [22]. Among the immunologically competent cells, macrophages
play a major role in the initiation and maintenance of immune response both innate and
adaptive [15]. In addition to the functions of phagocytosis and the release of lysosomal
enzymes, macrophages are also responsible for the release of a number of cytokines and
inflammatory mediators can stimulate the immune system in general [22].
The β-glucan belongs to the class of substances BRMs, or a variety of different substances
known as Biological Response Modifiers. being able to trigger a series of events in the immune
response [23], increasing the immune defense of the host by activating the functions of cells of
the immune system [20]. This polymer is currently considered as one of the most potent
stimulators of the immune response, effective both orally or intravenously, completely non-
toxic and safe [15]. The response of β-glucan in vertebrates begins with its recognition by
receptors present on the cell surface of various immune cells, such as macrophages, neutro‐
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phils, dendritic cells, and natural killer cells (NK), and receptors have also been described
presently as non-immune cells, endothelial cells, fibroblasts, alveolar epithelial, and Langer‐
hans cells [20]. The various receptors present on the cell membranes of immune cells related
to the recognition of β-glucan in vertebrates are dectin-1, complement receptor 3 (CR3),
lactosylceramide receptor, Toll-like receptor 2 (TLR-2), and scavenger receptors [24, 25]. The
dectin-1 is a type II transmembrane protein with receptor extracellular domain CDR which is
responsible for carbohydrate recognition, and a cytoplasmic tail with immunoreceptor
ITAM (tyrosine-based activating motif) involved in superoxide production by macrophages
in response to the immunosystem defense. The dectin-1 can mediate diverse cellular respons‐
es, including phagocytosis and endocytosis. This protein may also induce the production of
cytokines and inflammatory chemokines, such as tumor necrosis factor (TNF-α), macro‐
phage inflammatory protein-2 (MIP-2), and interleukin-12 (IL-12) [16]. The receptor CR3
stimulates cytokine secretion by NK cells, especially in the presence of pathogens. This receptor
acts as a cell adhesion molecule since it has a binding site for carbohydrates located on the
terminal carbon, and thus a receptor for the phagocyte β-glucan [15].
3.2. Medical application: cancer
Anticarcinogenic substances are able to reduce, delay, or even prevent the development of
malignancies [26]. Different studies have shown anticarcinogenic action of β-glucans and their
derivatives [1, 2, 4]. At the end of 1970s, a study on mice with subcutaneous tumor implanta‐
tion revealed that extracts containing high concentrations of β-glucan significantly reduced
growth of mammary carcinomas and melanomas in animals treated and verified an increase
in survival of these animals [27]. Kogan et al. [6] observed increased inhibition in the occur‐
rence of lung metastases up to 94% in animals that received oral administration of β-glucan
during treatment with cyclophosphamide for Lewis lung carcinoma. Several surveys show the
effectiveness of antitumor action of β-glucans in chemotherapy and the improvement in the
survival of patients with different types of cancer. A study involving women with malig‐
nant breast tumors confirmed the activation and proliferation of monocytes in peripheral blood
of patients upon oral administration of β-glucan. According to the researchers, clinical
improvement in the survival of patients with no evidence of any recurrent side effects was
demonstrated [4]. The effective immune response against tumor cells mediated by β-glucans
is based on the activation and expansion of several immune functions, among them the
activation of cytotoxic T cells specifically attack cancer cells [28]. The CD4+ T lymphocytes play
a role as modulators of immune cells to produce multiple cytokines. The latter are mediators
essential for the generation of an effective immune response involving CD8+ T cells, which are
necessary for the defense against tumor cells [1]. The effects of β-glucan in lymphocyte
activation involving the antitumor immune response have been reported in experimental
animal and human models. A study of 30 patients with advanced prostate cancer, who were
treated by oral administration of a soluble fraction of β-glucan (carboxymethyl glucan),
revealed that after administration there was a significant increase in CD3+, CD4+, and CD8+
in peripheral blood of patients and consequent stimulation of the immune system [2].
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3.3. β-glucans applied in other diseases
Since β-glucans affect immune function stimulating various immune cell activations, studies
were performed to demonstrate the effective application of this immunomodulatory com‐
pound in treatment of diseases. Patients with severe periodontitis have failed for the recruit‐
ment and activation of macrophages [29]. β-glucans induce macrophage activation and
establishment of Th1, and their use may be responsible for the inhibition of tissue destruc‐
tion in periodontal disease. The use of β-glucan in dental treatment has been systematically
evaluated in recent years. Studies with animals showed a significantly reduced periodontal
bone loss after oral administration of β-(1-3),(1-6) glucan [30]. Acar et al. [31] investigated the
effects of non-surgical periodontal therapy (NPT) with an adjunctive use of systemic β-glucan
on clinical, microbiological, and gingival parameters. Their findings showed that β-glucan
might increase the concentration of TGF-β1, thereby augmenting periodontal healing
potential. Proposals for treating allergic diseases using β-glucans have also been reported. A
new therapeutic strategy for allergic diseases using β-glucan was proposed, with beneficial
action in restoring the function of type 2 T-helper cells. Through the application of subcuta‐
neous injections in child patients, β-glucan was demonstrated to be able to modulate allergic
sensitization in patients, greatly improving their quality of life [32]. Furthermore, the antibac‐
terial, antiviral, and antifungal properties of β-glucan and its derivatives are also reported.
Different studies have shown the protective effect of β-glucan to Staphylococcus aureus [33],
Pneumocystis carinii, Leishmania donovani, and Influenza virus [22]. The protective effect of β-
glucan from S. cerevisiae against DNA damage and cytotoxicity in wild-type (k1) and repair-
deficient xrs5 CHO cells were evaluated by Oliveira et al. [34].
3.4. Food and feed applications of β-glucans
The search for higher human living standards and greater longevity has generated the need
for the development of nutritional alternatives that result in improved general health which
means more enjoyment of life, less diseases and less time, and money required for medical
needs. In this context, special foods enriched with molecules with health benefits are been
developed. Some studies dealing with the enormous benefits of β-glucan as a nutritional
supplement [31, 35–37]. Used as adjunctive to the positive effects of antioxidants, lipid balance
enhancers, antibiotics, and other therapeutics, the β-glucans are currently considered a true
antiaging supplement. These properties are associated with several studies which have shown
biological activity of β-glucan, describing its action modulating the immune system and
antitumor action [1, 3].
3.4.1. β-glucan in the human diet
In recent years, there has been increasing interest in the effect of the use of β-glucan as a dietary
supplement. Different studies seek to prove the use of this polysaccharide in the diet has
several health benefits. The beneficial effects of consistent intake of β-glucan and its action in
reducing cholesterol levels in the blood have been systematically studied. A study of 20
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hypercholesterolemic patients, who received daily dietary supplement containing 5.8 g of β-
glucan for 4 weeks, reported a 9% decrease in cholesterol level in the intervention group, while
there was no difference in the placebo (maltodextrin) group [7]. Nicolosi et al. [38] observed a
significant reduction in total and LDL cholesterol in hypercholesterolemic obese patients
after 8 weeks of intake of orange juice supplemented with β-glucan. The action of β-glucan on
cholesterol reduction can be explained in terms of the reduction in bile reabsorption or the
increase in viscosity in the small intestine. However, a more likely explanation relates to the
size of the molecule and its subsequent absorption by the intestine. According to Kim et al. [37],
molecules of small size, which are consequently less viscous, are less effective in lowering
cholesterol. Studies with β-glucan of low molecular size (370,000–1,000,000) reported this
polysaccharide ineffective in reducing the cholesterol level [39], whereas Braaten et al. [7]
reported a significant reduction in cholesterol levels in the blood of patients who included β-
glucan of molecular size above 1.2 million in their diet. β-glucans become a great special food
in a diet designed to adjunct in diabetic patients. The action of this polymer in lowering blood
glucose level is also reported in the literature. Research has demonstrated the antidiabetic effect
of IL-1 cytokine, which increases insulin production, resulting in the lowering of blood glucose
levels [40, 41]. Since the β-glucan acts on the activation of macrophages, and these are
considered the major source of IL-1 in the human body, this polymer becomes useful in diets
designed for diabetic patients. According to Regand et al. [42], the physiological activity of β-
glucan in reducing glycemic responses has been mostly attributed to its effect in increasing
viscosity in the upper digestive tract. The introduction of β-glucan in the diet may decrease
the incidence of colds, respiratory diseases, in addition to alleviating the symptoms caused by
these diseases, since this polymer increases the body’s potential to defend against invading
pathogens [31]. A study with seventy-five marathon runners showed that daily administration
of β-glucan can prevent upper respiratory tract (URTI) symptoms and improve overall health
and mood following a competitive marathon [36]. More recently, a study of 162 healthy
participants with recurring infections who received a diet supplemented with β-(1-3),(1-6)
glucan showed a reduction in the number of symptomatic common cold infections by 25% and
the mean symptom score was 15% lower compared to the control group [35].
3.4.2. β-glucan additives in animal feed
β-glucan has been prominent among the ingredients used as supplements in animal feed in
order to reduce the risk of chronic diseases both in mammals and in fish and birds [43], since
they are able to absorb mycotoxins, thus decreasing their toxic effect and mediating their
removal from the body [44]. Different food supplements containing β-glucan are available for
commercial use for animals. Among them, Bio-Mos® is used in the prevention of infectious
diseases of various origins and MTB100® in the elimination of the mycotoxins and inhibi‐
tion of their toxic effect, both manufactured by Alltech Inc. (Nicholasville, KY). Animals treated
with foods supplemented with β-glucan exhibit greater resistance to pathogenic microorgan‐
isms, and bacteria or viruses requiring lower dosages of antibiotics or antivirals to deal with
infections [5].
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4. Production of purified β-glucan
4.1. β-glucan extraction and purification by yeast cells
Many processes and raw materials of obtaining β-glucans have been described, but the
challenge is finding the best extraction leading to high purity with the great immunostimu‐
lant and antitumor action, periodontal therapy, among others. After the discovery of the
benefits of β-glucan for animals and humans, various processes of purification and isolation
of this polysaccharide have been developed [44]. The research for new methods of obtaining
β-glucan is being conducted prioritizing a non-aggressive extraction, which preserves the most
of the original structure of the macromolecule. Currently, β-glucan used as additive in feed is
produced by the cultivation of S. cerevisiae or as residue from the fuel ethanol or beer indus‐
try. In this respect, just the Brazilian production of sugar cane in the 2012/2013 harvest was
589 million tons of cane and 23.64 billion liters in ethanol was produced [45–47] with expect‐
ation of growing. The trading of β-glucan could be increased, since the yeast extraction from
the fuel ethanol distilleries up to 5% per day or 7.5 kg powder yeast per m3 ethanol/day would
be possible, which could reach at least 177,300 ton of yeast/day, only in the Brazilian fuel
ethanol industry.
4.1.1. Lysis of yeast cell
The basic process of β-glucan extraction involves the lysis of cells (chemical, biochemical,
mechanical, or by autohydrolysis), separation of cell wall (centrifugation or filtration),
extraction, and purification (precipitation and centrifugation). The yeast cells are normally
processed to produce β-glucan, mannan, and yeast extract. One important aspect of the
technology to produce β-glucan and other valuable products from yeasts is the method of cell
wall lysis. Yeast autolysis is used in the industrial processes due to the low cost, fractiona‐
tion efficiency, and quality of products obtained. Firstly, the fresh yeast cells are autolysed,
and the cell wall is separated by centrifugation.
The yeast cell wall has a thickness of 100–200 nm, and the wall is not only for protection and
structural function but is also metabolically important [48]. The thickness and structure of the
wall could vary depending on several factors like the strain, the industrial process of yeasts,
and culture conditions. The concentration of β-glucans also depends on these parameters since
the wall is used for the β-glucan extraction. The outer layer of mannoproteins retains the
periplasmic proteins conferring resistance to the cells of yeasts and acts as a barrier to external
attack of enzymes and some other molecules [49]. The layer of glucan is more internal and
linked with chitin in adjacent layers to the plasma membrane and confers rigidity and the cell
shape [50].
Autolysis is an irreversible process caused by intracellular enzymes of yeast under stress
conditions, such as temperature, pH, yeast concentrations unsuitable for the survival of the
cells. This process is based mainly on heat treatment and causes lysis of the cells from activation
of a group of intracellular enzymes that breaks the wall [51]. According to Nagodawithana
[51], lysis occurs primarily because of the enzymes β-(1-3) glucanase and protease. Enzymes
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β-(1-6) glucanases and mannanases participate in solubilizing the matrix of the cell wall, and
over forty enzymes have been identified in S. cerevisiae containing a major role in the autolyt‐
ic process. Probably due to metabolic differences between different strains of S. cerevisiae,
several studies disagree on the physicochemical conditions more appropriate for the autoly‐
sis of the cells vary from 45 to 55°C in 3–7 days of treatment [52]. The optimization of autoly‐
sis of Saccharomyces cerevisiae from a brewery was studied aiming at the maximum ribonucleic
acid extraction and yeast extract production [52]. The best conditions for yeast autolysis
were 55.2°C, pH = 5.1 and 9.8% NaCl in 24 h of processing. In these conditions, the RNA
extraction yield was 89.7%, resulting in 51.3% of dehydrated yeast extract with 57.9% protein,
and 48.7% cellular wall with 21.7% protein. The thermal shock at 60°C per 15 min prior to
autolysis provided an increase in this yield of 89.7–91.4%. The optimized autolysis including
NaCl plasmolysis was efficient, economic, and fast, thus usable for industrial purposes.
Currently, yeast residues are exported as yeast flour for feed at low prices by the countries
which are producers of fuel ethanol and beer. The improvement of the technology of fractio‐
nation and purification in other products like β-glucan, RNA, mannan, mannoprotein, and
others is strategic since more valuable products can be produced. This is in accordance with
the concept of biorefinery, that is, co-production of biofuels, bioenergy, and marketable
chemicals from renewable biomass [53].
Thereafter, the β-glucan is extracted from autolysed yeast cells by hot alkaline hydrolysis
(NaOH) and purified by citric acid precipitation. Another combination of alkali and inorgan‐
ic acid to extract β-(1-3) glucan was performed by Sandula et al., [54], followed the method
described by Machová et al., [55] to obtain water-insoluble β-(1-3) glucan from S. cerevisiae. In
this method, 6% NaOH solution at 60°C was also used; however, the extraction was done by
4% phosphoric acid at room temperature [56]. The effects of drying were evaluated in three
different processes (lyophilization, spray drying, and solvent precipitation) on the physical
properties and immunoregulatory effect of β-glucan of Saccharomyces.
4.2. Chemical modification of β-1,3 glucan
The research of modification of β-1,3 glucan has been performed aiming to improve biologi‐
cal properties. Others steps to obtain modified glucan like methylation, permethylation,
carboxymethylation, sulfoethylation, and ultrasonication Depending on the application or use
of this molecule. Carboxymethylation of the glucans was made with glucan or chitin–glucan
complex suspended in a mixture with 30% NaOH and isopropanol, and stirred at 10°C for 1
h. The degree of substitution of the carboxymethylated glucan was 0.56 or 0.91 for glucan
and 0.43 for chitin–glucan complex, depending on the amount of monochloroacetic acid
used [57]. The procedure of sulfoethylation of the glucans was performed using sodium β-
chloroethylsulfonate in isopropanol solution [58], and permethylation of baker’s yeast glucan
was carried out according to Ciucanu & Kerek [59] using powdered NaOH. The immunomo‐
dulatory activity was detected in fibrillar (non-soluble) and partially hydrolyzed baker’s yeast
glucan as well as its soluble derivatives prepared by carboxymethylation and sulfoethyla‐
tion. All these glucans showed anti-infective activity against Klebsiella pneumoniae after
intravenous or subcutaneous prophylactic application to mice [60].
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The evolution of β-(1,3) glucan use in the pharmaceutical and medical areas, as well as food
and feed, depends on the development of more economical and efficient methods of extrac‐
tion, purification, and chemical modification of this interesting molecule. Although their
biological properties are amply evidenced, more studies are needed about its application,
making this knowledge more available to benefit the health of human and animal.
5. Conclusion
β-(1-3) glucan is a promising healthier food and feed additive whose special properties certified
ranging from the activation of the immune system, replacement of antibiotics in animal
production, particularly for fish and pork, and various therapies: antitumor, allergic and
respiratory diseases, periodontitis and peritonitis. This polymer has also proven to be available
as food ingredient for the control of cholesterol and diabetes in special foods. Despite having
started their studies for some decades, this molecule remains expensive and not widely
available, with the technology dominated by a few producers.
The extraction methods using alkali and acid, with previous pre-treatments, and the step of
purification and chemical modification, are needed to obtain β-glucan according to specific
biological properties. The solubility, molecular size, level of protein, and degree of methyla‐
tion are essential parameters to be considered for these properties. This work also highlight‐
ed some technological aspects of economic obtaining of β-glucan from yeast.
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